Skip to Main Content

Author Details

Yong-Man Kim
Asan Medical Center, University of Ulsan College of Medicine
1994
247
50
PMIDPaper TitleJournal TitlePublished Year
36596856CD8α+⿿dendritic cells potentiate antitumor and immune activities against murine ovarian cancers.Sci Rep2023
37593814East Asian Gynecologic Oncology Trial Group (EAGOT): founding history and future perspective.J Gynecol Oncol2023
37578339Application of preoperative fluorodeoxyglucose-PET/CT parameters for predicting prognosis of high-grade neuroendocrine cervical cancer.Nucl Med Commun2023
37541685Pathological findings and long-term prognosis in Korean BRCA1/2 mutation carriers undergoing risk-reducing salpingo-oophorectomy.Int J Gynecol Cancer2023
37976756Immune checkpoint inhibitors with chemotherapy for primary advanced mismatch repair-deficient endometrial cancer: A cost-effectiveness analysis.Gynecol Oncol2023
37082675PARP inhibitors, use early in the first-line maintenance therapy setting but with caution.Ann Transl Med2023
37477099Outcomes and prognostic factors of surgically treated extramammary Paget's disease of the vulva.J Gynecol Oncol2023
36789760Stratifying the risk of ovarian cancer incidence by histologic subtypes in the Korean Epithelial Ovarian Cancer Study (Ko-EVE).Cancer Med2023
35139273Survival with Cemiplimab in Recurrent Cervical Cancer.N Engl J Med2022
35670036Two-year efficacy of SNK01 plus pembrolizumab for non-small cell lung cancer: Expanded observations from a phase I/IIa randomized controlled trial.Thorac Cancer2022
35666535Somatic genomic landscape of East Asian epithelial ovarian carcinoma and its clinical implications from prospective clinical sequencing: A Korean Gynecologic Oncology Group study (KGOG 3047).Int J Cancer2022
35922251EMPOWER CERVICAL-1: Effects of cemiplimab versus chemotherapy on patient-reported quality of life, functioning and symptoms among women with recurrent cervical cancer.Eur J Cancer2022
35045221Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer.N Engl J Med2022
34856706A Phase I/IIa Randomized Trial Evaluating the Safety and Efficacy of SNK01 Plus Pembrolizumab in Patients with Stage IV Non-Small Cell Lung Cancer.Cancer Res Treat2022
32815448Usefulness of sentinel lymph node mapping using indocyanine green and fluorescent imaging in the diagnosis of lymph node metastasis in endometrial cancer.J Obstet Gynaecol2021
33567699New Surgical Technique for Robotic Myomectomy: Continuous Locking Suture on Myoma (LSOM) Technique.J Clin Med2021
33871703Real-world experience of olaparib as maintenance therapy in BRCA-mutated recurrent ovarian cancer.Arch Gynecol Obstet2021
33842272Role of minimally invasive surgery in early ovarian cancer.Gland Surg2021
34502561Application of Immunoprofiling Using Multiplexed Immunofluorescence Staining Identifies the Prognosis of Patients with High-Grade Serous Ovarian Cancer.Int J Mol Sci2021
34501409Single-Incision versus Multiport Robotic Myomectomy: A Propensity Score Matched Analysis of Surgical Outcomes and Surgical Tips.J Clin Med2021
34657357Prevalence and clinical characterization of BRCA1 and BRCA2 mutations in Korean patients with epithelial ovarian cancer.Cancer Sci2021
34158629Verrucomicrobial methanotrophs grow on diverse C3 compounds and use a homolog of particulate methane monooxygenase to oxidize acetone.ISME J2021
34326007Safety of autologous bone marrow-derived mesenchymal stem cells in erectile dysfunction: an open-label phase 1 clinical trial.Cytotherapy2021
34279158The Clinical Significance and Utility of HPV-DNA Testing in Korean Women with Atypical Glandular Cells in Cervical Pap Tests: An Analysis of 311 Cases at a Single Institution.Cancer Invest2021
33246662Continued medical treatment for persistent early endometrial cancer in young women.Gynecol Oncol2021
32566022Comparison of Risk of Ovarian Malignancy Algorithm and cancer antigen 125 to discriminate between benign ovarian tumor and early-stage ovarian cancer according to imaging tumor subtypes.Oncol Lett2020
31907386Impact of proactive high-throughput functional assay data on BRCA1 variant interpretation in 3684 patients with breast or ovarian cancer.J Hum Genet2020
32084588Prognostic Factors and Impact of Minimally Invasive Surgery in Early-stage Neuroendocrine Carcinoma of the Cervix.J Minim Invasive Gynecol2020
31948126Phase I Study of a B Cell-Based and Monocyte-Based Immunotherapeutic Vaccine, BVAC-C in Human Papillomavirus Type 16- or 18-Positive Recurrent Cervical Cancer.J Clin Med2020
31708114Comparison of CA 125 alone and risk of ovarian malignancy algorithm (ROMA) in patients with adnexal mass: A multicenter study.Curr Probl Cancer2020
31942468Establishment of NOAEL for intracavernous injections of human bone marrow-derived mesenchymal stem cells in rats.Investig Clin Urol2020
33251780Robot-Assisted Laparoscopic Myomectomy versus Abdominal Myomectomy for Large Myomas Sized over 10 cm or Weighing 250 g.Yonsei Med J2020
33138190Real-World Experience of Pembrolizumab Monotherapy in Patients with Recurrent or Persistent Cervical Cancer: A Korean Multi-Center Retrospective Study (KGOG1041).Cancers (Basel)2020
33078594Feasibility and safety of fertility-sparing surgery in epithelial ovarian cancer with dense adhesion: a long-term result from a single institution.J Gynecol Oncol2020
33271094Pembrolizumab plus GX-188E therapeutic DNA vaccine in patients with HPV-16-positive or HPV-18-positive advanced cervical cancer: interim results of a single-arm, phase 2 trial.Lancet Oncol2020
32928923Low value of staging in detecting extraovarian occult metastasis in mucinous borderline ovarian tumors.Int J Gynecol Cancer2020
32812259Performance evaluation of an amplicon-based next-generation sequencing panel for BRCA1 and BRCA2 variant detection.J Clin Lab Anal2020
32442924Feasibility and efficacy of gonadotropin-releasing hormone agonists for the prevention of chemotherapy-induced ovarian insufficiency in patients with malignant ovarian germ cell tumours (KGOG 3048R).Eur J Cancer2020
32234846IGCS Intraoperative Technology Taskforce. Update on near infrared imaging technology: beyond white light and the naked eye, indocyanine green and near infrared technology in the treatment of gynecologic cancers.Int J Gynecol Cancer2020
32161019GeneReader NGS System Is a Useful Sequencing Platform for Clinical Testing of <i>BRCA1</i> and <i>BRCA2</i>.Ann Clin Lab Sci2020
29510610Development and Validation of Ovarian Symptom Index-18 and Neurotoxicity-4 for Korean Patients with Ovarian, Fallopian Tube, or Primary Peritoneal Cancer.Cancer Res Treat2019
31777741Endometrial thickness cut-off value by transvaginal ultrasonography for screening of endometrial pathology in premenopausal and postmenopausal women.Obstet Gynecol Sci2019
31590408An Improved Prediction Model for Ovarian Cancer Using Urinary Biomarkers and a Novel Validation Strategy.Int J Mol Sci2019
31329907The combination of histone deacetylase and p53 expressions and histological subtype has prognostic implication in uterine leiomyosarcoma.Jpn J Clin Oncol2019
31189035Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer.N Engl J Med2019
30887755Prospective study of the efficacy and utility of TP53 mutations in circulating tumor DNA as a non-invasive biomarker of treatment response monitoring in patients with high-grade serous ovarian carcinoma.J Gynecol Oncol2019
30971164Hydroxychloroquine treatment during pregnancy in lupus patients is associated with lower risk of preeclampsia.Lupus2019
30599784Histologic Correlation and Clinical Significance of Atypical Glandular Cells on Cervical Pap Tests: Analysis of 540 Cases at a Single Institution.Cancer Invest2019
30591474Assessment of the Applicability of Integrative Tumor Response Assays in Advanced Epithelial Ovarian Cancer.Anticancer Res2019
30409490Real-world effectiveness of bevacizumab based on AURELIA in platinum-resistant recurrent ovarian cancer (REBECA): A Korean Gynecologic Oncology Group study (KGOG 3041).Gynecol Oncol2019
  • 1 - 50 of 247

Recommended Authors

Yingmei Wang
Tianjin Medical University General Hospital
Career Start Year 2007
Number of shared co-authors 0
Divya Gupta
Emory University School of Medicine
Career Start Year 2006
Number of shared co-authors 0
Donal J Brennan
National Centre for Peritoneal Malignancy, Mater Misericordiae University Hospital
Career Start Year 2005
Number of shared co-authors 0
Fan Zhang
Huaihe Hospital of Henan University
Career Start Year 2004
Number of shared co-authors 0
Lin Qi
Xiangya Hospital of Central South University
Career Start Year 2003
Number of shared co-authors 1
Sven Mahner
University Hospital
Career Start Year 2002
Number of shared co-authors 1
Maria Del Pilar Estevez Diz
Instituto do Cancer do Estado de Sao Paulo and Universidade de Sao Paulo
Career Start Year 2002
Number of shared co-authors 0
Aparna A Kamat
Houston Methodist Hospital
Career Start Year 2000
Number of shared co-authors 0
Douglas A Levine
Perlmutter Cancer Center
Career Start Year 1999
Number of shared co-authors 2
Susan C Modesitt
University of Virginia, Emily Couric Clinical Cancer Center
Career Start Year 1998
Number of shared co-authors 0
Woo Young Kim
Westchester Medical Center
Career Start Year 1998
Number of shared co-authors 1
Kevin Holcomb
Weill Cornell Medical College
Career Start Year 1996
Number of shared co-authors 0
Sang Yong Song
Center for Nanophase Materials Sciences, Oak Ridge National Laboratory
Career Start Year 1995
Number of shared co-authors 5
Paulette Mhawech-Fauceglia
University of Southern California
Career Start Year 1995
Number of shared co-authors 0
Annette Hasenburg
University Medical Center, Johannes Gutenberg University Mainz
Career Start Year 1994
Number of shared co-authors 1
Ernst Lengyel
University of Chicago
Career Start Year 1993
Number of shared co-authors 0
Rosalind Glasspool
University of Glasgow
Career Start Year 1992
Number of shared co-authors 3
Yong-Wan Kim
Inje University Haeundae Paik Hospital
Career Start Year 1992
Number of shared co-authors 1
George L Maxwell
Women's Health Integrated Research Center, Inova Health System
Career Start Year 1992
Number of shared co-authors 0
Anil K Sood
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 3
Gustavo C Rodriguez
Clinica Quirurgica 2 (Surgical Clinic 2), Hospital Maciel
Career Start Year 1990
Number of shared co-authors 2
Kathleen M Darcy
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
Career Start Year 1990
Number of shared co-authors 0
Fr??d??ric Amant
Netherlands Cancer Institute
Career Start Year 1989
Number of shared co-authors 1
Tanja Pejovic
Oregon Health & Science University
Career Start Year 1989
Number of shared co-authors 1
Sun Young Kim
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 1988
Number of shared co-authors 4
Cyril B Gilks
University of British Columbia
Career Start Year 1987
Number of shared co-authors 2
Gary L Keeney
Mayo Clinic
Career Start Year 1984
Number of shared co-authors 1
Andrew Berchuck
Duke School of Medicine
Career Start Year 1983
Number of shared co-authors 2
Beth Y Karlan
David Geffen School of Medicine, University of California los angeles
Career Start Year 1981
Number of shared co-authors 2
Anna DeFazio
Westmead Hospital
Career Start Year 1972
Number of shared co-authors 2

Collaborators

Shin-Wha Lee
Asan Medical Center, University of Ulsan College of Medicine
Co-authored papers 52
Jeong-Won Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 12
Hyun-Soo Kim
Wonju Severance Christian Hospital
Co-authored papers 9
Ha Young Lee
Daegu Gyeongbuk Institute of Science and Technology (DGIST)
Co-authored papers 6
Choung-Soo Kim
Asan Medical Center, University of Ulsan College of Medicine
Co-authored papers 6
Jong Hoon Kim
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 4
Ji Eun Oh
College of Science & Industry Convergence, Ewha Womans University
Co-authored papers 3
Sangdun Choi
Ajou University
Co-authored papers 3
Mee-Yon Cho
Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine
Co-authored papers 2
Martha Quezado
National Cancer Institute (NCI), National Institutes of Health (NIH)
Co-authored papers 2
David G Standaert
University of Alabama at Birmingham
Co-authored papers 1
William C Hahn
Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute
Co-authored papers 1
Steven M Hersch
Inc. University Avenue
Co-authored papers 1
Isabelle Ray-Coquard
University Claude Bernard Lyon I
Co-authored papers 1
Chang-Yuil Kang
Co-authored papers 1
Byung Seok Kim
Catholic University of Daegu School of Medicine
Co-authored papers 1
Robert M Hoffman
Co-authored papers 1
Hyo Joo Bang
Ahngook Pharmaceutical Co.
Co-authored papers 1
Jong-Won Kim
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 1
Jason K Sa
Korea University, College of Medicine
Co-authored papers 1
George D Yancopoulos
Co-authored papers 1
Laura E MacConaill
Co-authored papers 1
Paul Van Hummelen
Co-authored papers 1
Yong-Joon Chwae
Ajou University School of Medicine
Co-authored papers 1
Robert J Linhardt
Rensselaer Polytechnic Institute
Co-authored papers 1
Sek Won Kong
Boston Children's Hospital, Seoul National University, Seoul National University Hospital
Co-authored papers 1
Hye-Jeong Song
Bio-IT Research Center, Hallym University
Co-authored papers 1
Release 1.2